skip to content

Catalysis and Process Integration

 

Our PhD student Julien Mahin was mentioned in the CEB department news.

“It’s challenging because what you're trying to do is control material formation on a very, very small scale – a few nanometres,” says Mahin. “What's important for biomedical applications is that you know exactly what you're putting in your body. When pharmaceutical companies develop drugs, they want to know exactly what's in it and it takes a long time to make sure it's safe. With nanoparticles, size is one of the most important properties because it will determine other properties of the particle so we need to have particles of a very well defined size.”